Overview
No overview information available.
Background
No background information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Bracco Diagnostics Inc | 0270-0445 | ORAL, RECTAL | 660 mg in 1 mL | 4/23/2018 | |
| BRACCO DIAGNOSTICS INC | 0270-0149 | INTRAVENOUS | 300 mg in 1 mL | 4/15/2018 | |
| Guardian Drug Company | 53041-688 | ORAL, RECTAL | 660 mg in 1 mL | 12/18/2020 | |
| Liebel-Flarsheim Company LLC | 0019-4816 | ORAL, RECTAL | 600 mg in 1 mL | 2/15/2017 | |
| Camber Pharmaceuticals, Inc. | 31722-019 | ORAL, RECTAL | 660 mg in 1 mL | 12/18/2023 | |
| BRACCO DIAGNOSTICS INC | 0270-1410 | INTRAVESICAL | 180 mg in 1 mL | 10/2/2018 | |
| Guardian Drug Company | 53041-690 | ORAL, RECTAL | 660 mg in 1 mL | 12/18/2020 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||